MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 6, 2007; DOI: 10.1124/mol.107.034413


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034413v1
72/3/526    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottle, M.
Right arrow Articles by Seifert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottle, M.
Right arrow Articles by Seifert, R.


Received for publication January 24, 2007.
Revised June 6, 2007.
Accepted for publication June 6, 2007.

Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides

Martin Gottle 1, Stefan Dove 1, Philip Steindel 1, Yuequan Shen 2, Wei-Jen Tang 3, Jens Geduhn 1, Burkhard Konig 1, Roland Seifert 1*

1 University of Regensburg 2 Nankai University 3 University of Chicago

* Address correspondence to: E-mail: roland.seifert{at}chemie.uni-regensburg.de

Abstract

The calmodulin (CaM)-dependent adenylyl cyclase (AC) toxin from Bordetella pertussis (CyaA) substantially contributes to the pathogenesis of whooping cough. Thus, potent and selective CyaA inhibitors may be valuable drugs for prophylaxis of this disease. We examined the interactions of fluorescent 2',3'-N-methylanthraniloyl (MANT)-, anthraniloyl- and trinitrophenyl (TNP)-substituted nucleotides with CyaA. Compared to mammalian AC isoforms and Bacillus anthracis AC toxin edema factor, nucleotides inhibited catalysis by CyaA less potently. Introduction of the MANT substituent resulted in 5 to 170-fold increased potency of nucleotides. Ki-values of 3'MANT-2'd-ATP and 2'MANT-3'd-ATP in the AC activity assay using Mn2+ were 220 nM and 340 nM, respectively. Natural nucleoside 5’-triphosphates, guanine-, hypoxanthine- and pyrimidine-MANT- and TNP-nucleotides and di-MANT-nucleotides inhibited CyaA, too. MANT-nucleotide binding to CyaA generated fluorescence resonance energy transfer (FRET) from tryptophans W69 and W242 and multiple tyrosine residues, yielding Kd-values of 300 nM for 3'MANT-2'd-ATP and 400 nM for 2'MANT-3'd-ATP. Fluorescence experiments and docking approaches indicate that the MANT- and TNP groups interact with F306. Increases of FRET and direct fluorescence with MANT-nucleotides were strictly CaM-dependent, whereas TNP-nucleotide fluorescence upon binding to CyaA increased in the absence of CaM and was actually reduced by CaM. In contrast to low-affinity MANT-nucleotides, even low-affinity TNP-nucleotides generated strong fluorescence increases upon binding to CyaA. We conclude that the catalytic site of CyaA possesses substantial conformational freedom to accommodate structurally diverse ligands and that certain ligands bind to CyaA even in the absence of CaM, facilitating future inhibitor design.


Key words: Adenylyl cyclases, cAMP, Structure-activity relationships and modeling, Fluorescence techniques, Protein targets, Antibiotic mechanisms





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics